Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP

Clinical trial NCT07057778 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07057778
Sponsor: Peking University People's Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Immune Thrombocytopenia (ITP)

Start date: 2025-07-01
Primary completion: 2026-12-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.